Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Moderate to Severe Atopic Eczema”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT06173284
What this trial is testing

Evaluation of 611(Recombinant Humanized Anti-interleukin-4 Receptor Alpha IgG4 Monoclonal Antibody) in Chinese Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 519
Not applicableActive Not RecruitingNCT03687359
What this trial is testing

Observational Evaluation of Atopic Dermatitis in Pediatric Patients

Who this might be right for
Dermatitis Atopic
Sanofi 1,860
Testing effectiveness (Phase 2)Active Not RecruitingNCT06727552
What this trial is testing

Barzolvolimab in Patients With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Celldex Therapeutics 131
Early research (Phase 1)Study completedNCT00757042
What this trial is testing

Safety Study of Tezepelumab (AMG 157) in Healthy Adults and Adults With Atopic Dermatitis

Who this might be right for
Atopic DermatitisHealthy Volunteers
Amgen 78
Testing effectiveness (Phase 2)Study completedNCT04921345
What this trial is testing

Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Moderate-to-Severe Atopic Dermatitis
Galderma R&D 109
Large-scale testing (Phase 3)Study completedNCT00691145
What this trial is testing

Study to Evaluate the Efficacy and Safety of 0.1% and 0.03% Tacrolimus Ointment Administered in Adults With Moderate to Severe Atopic Dermatitis

Who this might be right for
Dermatitis, Atopic
Astellas Pharma Inc 350
Not applicableLooking for participantsNCT05026554
What this trial is testing

Characterization of Chronic Hand Eczema

Who this might be right for
Chronic Hand EczemaAtopic Dermatitis
Dr. Robert Bissonnette 270
Not applicableStudy completedNCT01714245
What this trial is testing

Evaluate CLn® BodyWash As Added Therapy in Eczema Patients

Who this might be right for
EczemaAtopic Dermatitis
TopMD Skin Care, Inc. 50
Testing effectiveness (Phase 2)Looking for participantsNCT07298395
What this trial is testing

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Enveda Therapeutics 105
Large-scale testing (Phase 3)Study completedNCT05032859
What this trial is testing

Tapinarof for the Treatment of Atopic Dermatitis in Children and Adults (DMVT-505-3102)

Who this might be right for
Atopic Dermatitis
Organon and Co 406
Testing effectiveness (Phase 2)Study completedNCT06015308
What this trial is testing

Investigate Vaccine Responses in Subcutaneous Amlitelimab Treated Atopic Dermatitis Participants Aged 18 Years and Older Compared With Placebo

Who this might be right for
Dermatitis Atopic
Sanofi 224
Large-scale testing (Phase 3)Study completedNCT03738397
What this trial is testing

Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
AbbVie 673
Testing effectiveness (Phase 2)Study completedNCT03915496
What this trial is testing

Study Evaluating the Mechanism of Action of PF-04965842 Monotherapy for Moderate-to-severe Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
Pfizer 46
Large-scale testing (Phase 3)UnknownNCT05004324
What this trial is testing

Safety and Efficacy of FURESTEM-AD Inj. for Moderate to Severe Atopic Dermatitis (AD)

Who this might be right for
Dermatitis, Atopic
Kang Stem Biotech Co., Ltd. 308
Large-scale testing (Phase 3)Study completedNCT02601703
What this trial is testing

To Study Generic Tacrolimus Ointment, 0.1% in the Treatment of Moderate to Severe Atopic Dermatitis (Inflammation of Skin: Itchy, Red, Swollen, and Cracked Skin)

Who this might be right for
Atopic Dermatitis
Glenmark Pharmaceuticals Ltd. India 1,110
Testing effectiveness (Phase 2)Ended earlyNCT05399368
What this trial is testing

An Efficacy and Safety Study of RPT193 in Adults With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis
RAPT Therapeutics, Inc., a member of the GSK plc group of companies 229
Not applicableUnknownNCT05023668
What this trial is testing

China Atopic Dermatitis Registry Study

Who this might be right for
Dermatitis, Atopic
Peking University People's Hospital 10,000
Not applicableLooking for participantsNCT07746427
What this trial is testing

Digital Mindfulness Meditation in Adolescents With Atopic Dermatitis

Who this might be right for
Atopic DermatitisEczema
Weill Medical College of Cornell University 40
Early research (Phase 1)Study completedNCT05197023
What this trial is testing

EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETICS, AND PHARMACODYNAMICS OF MULTIPLE SUBCUTANEOUS INJECTIONS OF SHR-1819 IN PATIENTS WITH MODERATE TO SEVERE ATOPIC DERMATITIS

Who this might be right for
Moderate to Severe Atopic Dermatitis
Shanghai Hengrui Pharmaceutical Co., Ltd. 21
Testing effectiveness (Phase 2)Study completedNCT07103174
What this trial is testing

MG-K10 Humanized Monoclonal Antibody Injection in Subjects With Atopic Dermatitis

Who this might be right for
Atopic Dermatitis (AD)
Shanghai Mabgeek Biotech.Co.Ltd 60
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation